Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.
Saved in:
| Title: | Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study. |
|---|---|
| Authors: | Ozkerim, Ugur1 (AUTHOR) ugur.ozkerim@hotmail.com, Isik, Deniz1 (AUTHOR), Kinikoglu, Oguzcan1 (AUTHOR), Oksuz, Sila1 (AUTHOR), Altintas, Yunus Emre1 (AUTHOR), Akdag, Goncagul1 (AUTHOR), Yildirim, Sedat1 (AUTHOR), Basoglu, Tugba1 (AUTHOR), Surmeli, Heves1 (AUTHOR), Odabas, Hatice1 (AUTHOR), Turan, Nedim1 (AUTHOR) |
| Source: | Journal of Personalized Medicine. Jan2026, Vol. 16 Issue 1, p8. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
